HIGHLIGHTS
- who: Teije van Prooije from the potential cost-effectiveness of RNA-based therapies for , in the Netherlands have published the research work: The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study, in the Journal: (JOURNAL)
- what: By developing a health economic model the authors aimed to provide first insights into the potential cost-effectiveness of RNA-based therapies for SCA1 in the Netherlands. The authors aimed to develop a health economic model that evaluates how a potentially disease-modifying treatment, such as AON therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.